Egalet US INC.

Pharmaceutical company that develops and commercializes abuse-deterrent formulations.

Based in PA

🤖

AI Overview

With $200K in lobbying spend across 5 quarterly filings, Egalet US INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2019.

$200K
Total Spend
2
Years Active
1
Firms Hired
3
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$200K
2019$0

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid

  • Advocated for access to abuse-deterrent formulations.
  • Advocated for access to abuse-deterrent formulations. Support for H.R. 5582 - Abuse Deterrent Access Act of 2018. Support for Sec. 6001 of H.R. 6 - SUPPORT for Patients and Communities Act.
  • Advocated for access to abuse-deterrent formulations. Support for Sec. 6012 of H.R. 6 - SUPPORT for Patients and Communities Act.
  • Support for H.R. 5582 - Abuse Deterrent Access Act of 2018.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.